Although the Magnificent 7 tech stocks have been the primary drivers for the bullish S&P 500 run over the past few years, ...

UBS analyst Karl Keirstead maintained a Buy rating on Microsoft (MSFT – Research Report) today and set a price target of $510.00. The company’s ...

UBS analyst Karl Kierstead reaffirmed a Buy rating on Microsoft (NASDAQ:MSFT) stock, maintaining a price target of $510.00.

The report comes a week after GameStop CEO Ryan Cohen posted a photo on X of him and the bitcoin evangelist and Strategy ...

An industry-leading position and strong secular tailwinds should help drive this artificial intelligence (AI) pioneer higher.

Some fund managers and ASX ETF index managers are choosing only to invest in some of the US Magnificent Seven stocks these ...

High-yield stocks face risks, but two sectors are thriving. Learn why my top picks in these sectors are poised for success in ...

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

OCI was built with flexibility and ease-of-use in mind, which could bring a significant base of first-time Oracle users to the company. Artificial Intelligence demand should boost growth further. We ...

If you're ready to move beyond Magnificent Seven stocks, there's a new acronym on Wall Street with one key addition.

Down 50% from all-time highs, Brookfield Renewable is a top TSX dividend stock that trades at a sizeable discount to price ...

However, Nvidia ( NVDA 3.16%) has not fared as well in the past few months, and its situation may well get worse from here.